Clinical Trial Update: External Beam and Radioligand Radiotherapy for mCRPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a study of external beam radiotherapy combined with radioligand radiotherapy for metastatic castration-resistant prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Prostate Cancer Metastatic Castration-Resistant | Phase 2 | Status: NOT_YET_RECRUITING